Unlock Strategic Intelligence with Fundz

Access exclusive insights on funding rounds, strategic shifts with FundzWatch™, Family Offices, and more — faster than your competitors.

Graviton Bio Science announced it raised $39.8 Million in an initial filing from an offering of $50 Million

12/04/23, 8:11 PM

Location

new york

Money raised

$39.8 million

Industry

biotechnology

🔒 Strategic shifts and deeper insights are available for this company. Unlock full access to view hidden updates, executive moves, and more.

Company Info

Company

Graviton BioScience

Location

125 west end ave.

new york, new york, united states

Additional Info

Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.

Company news

Thu, 01 Feb 2024 08:00:00 GMT

Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors - PR Newswire

Mon, 01 Jul 2024 07:00:00 GMT

Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations - GlobeNewswire

Tue, 02 Jan 2024 08:00:00 GMT

Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors - PR Newswire

Track Every New Funding Round — Before Anyone Else

This is just a small preview. Unlock access to thousands more filtered results — updated in real-time by stage, region, investor & more.

Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.

Related people

Trends

	Raised	Growth The data in the raised column shows reported funding for this location/industry over last 90 days. The data in the growth column indicates the % increase or decrease of the last 90 days vs. the previous 90 days. Please note: one or more large fundings, especially for a location/industry that doesn't historically receive much funding, can have a significant impact on the increase or decrease percentage.
biotechnology	$9.4 B	-17.2%